Bio
Charles Mamrak brings over 20 years of life science and laboratory experience to Linden. Prior to joining Linden, Mr. Mamrak was CEO of PML Microbiologicals, where he and his team grew revenues 90% in under three years. He then engineered a highly profitable divestiture for their private equity investors to a strategic buyer. Prior to PML, Mr. Mamrak was CEO for a private equity backed contract packaging and manufacturing business focused on solid dose pharmaceuticals. Before his private equity experience, Mr. Mamrak held several general management posts at Fisher Scientific, leading both the Acros Organics North American and Global Custom Chemistry businesses. Mr. Mamrak also held senior positions with Sigma-Aldrich where he helped develop and launch their line of Discovery HPLC columns. Earlier in his career, Mr. Mamrak worked in and managed several contract research laboratories including DuPont, CH2M Hill and Corning Laboratories. Mr. Mamrak studied Biomedical Engineering at Pennsylvania State University and holds a Bachelors degree in Biology and Chemistry from Moravian College.
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Linden LLCEmail: [email protected] |